A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Conditions
mCRPC (Metastatic Castration-resistant Prostate Cancer) · Prostate Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
MemorialCare Orange Coast Medical Center, Fountain Valley, California, United States
Contact: Principal Investigator (Amol Rao, MD)Cancer and Blood Research Center, Los Alamitos, California, United States
Contact: Principal Investigator (Collin Vu, MD)University of Colorado Health, Aurora, Colorado, United States
Contact: Principal Investigator (Elaine Lam, MD)Mount Sinai Medical Center, Miami, Florida, United States
Contact: Principal Investigator (Bruno Bastos, MD)Emory University Hospital, Atlanta, Georgia, United States
Contact: Principal Investigator (Jordan Ciuro)University of Chicago, Chicago, Illinois, United States
Contact: Study coordinator (Mohammad Atiq, MD) · cancerclinicaltrials@bsd.uchicago.edu · 773-834-7002Contact: Principal Investigator (Mohammad Atiq)Community Health Network, Indianapolis, Indiana, United States
Contact: Principal Investigator (Natraj Ammakkanavar)Ochsner, Jefferson, Louisiana, United States
Contact: Principal Investigator (Brian Halbert)Johns Hopkins Hospital, Baltimore, Maryland, United States
Contact: Principal Investigator (Adel Mandl)Karmanos Cancer Institute, Detroit, Michigan, United States
Contact: Principal Investigator (Frank Cackowski, MD)Siteman Cancer Center, St Louis, Missouri, United States
Contact: Principal Investigator (Melissa Reimers, MD)Nebraska Cancer Specialists, Omaha, Nebraska, United States
Contact: Principal Investigator (Ralph Hauke, MD)Duke University medical center, Durham, North Carolina, United States
Contact: Principal Investigator (Andrew Armstrong, MD)The Ohio State University, Columbus, Ohio, United States
Contact: Principal Investigator (Lingbin Meng)Taylor Cancer Research Center, Maumee, Ohio, United States
Contact: Principal Investigator (John Nemunaitis)University of Texas Southwestern Medical Center, Dallas, Texas, United States
Contact: Principal Investigator (Tian Zhang, MD)Oncology Consultants, P.A, Houston, Texas, United States
Contact: Principal Investigator (Julio Peguero, MD)NEXT Oncology - Virginia, Fairfax, Virginia, United States
Contact: Principal Investigator (Mohamad Salkeni, MD)